Santhera Pharmaceuticals Holding AG (SPHDF)
11.70
0.00 (0.00%)
USD |
OTCM |
Jun 03, 16:00
Santhera Pharmaceuticals Debt to Equity Ratio: 0.3494 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.3494 |
| June 30, 2023 | -0.9489 |
| December 31, 2022 | -0.989 |
| June 30, 2022 | -2.821 |
| December 31, 2021 | 31.00 |
| June 30, 2021 | 4.907 |
| December 31, 2020 | -10.78 |
| June 30, 2020 | 276.65 |
| December 31, 2019 | 2.643 |
| June 30, 2019 | 6.496 |
| June 30, 2018 | 3.546 |
| June 30, 2017 | 0.9497 |
| December 31, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| June 30, 2011 | 0.0414 |
| December 31, 2010 | 0.0322 |
| June 30, 2010 | 0.0341 |
| December 31, 2009 | 0.0272 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-10.78
Minimum
Dec 2020
276.65
Maximum
Jun 2020
30.65
Average
1.496
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 130.52M |
| Total Liabilities (Quarterly) | 59.15M |
| Shareholders Equity (Quarterly) | 71.37M |
| Current Ratio | 0.7821 |
| Net Debt Paydown Yield | 4.03% |